Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Allergy Clin Immunol. 2020 Jun 12;146(4):851–862.e10. doi: 10.1016/j.jaci.2020.05.040

Figure 1: Subject Disposition:

Figure 1:

Participants passing a BE DBPCFC and subsequently failing an unbaked egg DBPCFC were randomized 1:1 to BE-R or OIT-R groups. Participants failing a BE DBPCFC were presumed reactive to unbaked egg without a DBPCFC and assigned to the OIT-A group. Enrollment in the OIT-A group was limited to 40 participants. All active participants underwent the year 1 and year 2 unbaked egg DBPCFCs. Subjects passing the year 2 DBPCFC discontinued BE or OIT therapy for 8-10 weeks before undergoing the SU DBPCFC. *One OIT-A participant had an inconclusive result for the year 1 DBPCFC.